StockTipsArenaBeta

BUY Rainbow Childrens Medicare Limited — Somil Mehta, Sharekhan

BUYRainbow Childrens Medicare Limited
Rainbow Childrens Medicare share price target & all analyst calls

bySomil Mehta, SharekhanHorizon: 1–3 months11 Nov 2026via Zee Business (Live)

Entry₹1,263Stated
Target₹1,390
Total upside +10.06%
Stop loss₹1,240-1.82% risk
CMP₹1,271.51d ago
Active+0.67%+9.32%upside left 3 mo left
Follow Somil Mehta for new calls(38% target hit, 98 closed calls)Get alertsWatch RAINBOW for new buy/sell callsGet alertsSee 83 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:24 am IST
5 supporting1 neutral1 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

8 advisors have active long-term BUY calls on this stock, with 4 issued in the last 14 days

Advisor consensus · adjacent horizon·3 Nov · 2w ago

Rainbow Children’s Medicare Q2: Revenue rises 23%, profit grows 11%

NewsCnbc-Tv18·31 Oct · 2w ago

(opens in new tab)

Rainbow Children's Medicare reported Q2 FY27 revenue growth of 23% year-on-year, with EBITDA and PAT growing by 14% and 11% respectively, driven by healthy patient volumes and network expansion.

BSE · Company Update·31 Oct · 2w ago

(opens in new tab)

Rainbow Children's Medicare reported Q2 FY27 revenue of INR 5,480 million, up 23% YoY, and PAT of INR 839 million, up 11% YoY, driven by operational growth and expansion.

BSE · Company Update·31 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (1)

Unaudited Standalone & Consolidated Financial Results for Quarter and Half year ended September 30, 2026

BSE · Board Meeting·31 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 73 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Rainbow Childrens Medicare

All analyst calls on Rainbow Childrens Medicare

More from Somil Mehta, Sharekhan

Every call and its outcome